XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue (note 13)    
Recurring - non-capital $ 6,806 $ 4,677
Capital equipment 393 2,004
Total revenue 7,199 6,681
Cost of sales (note 14) 2,817 3,660
Gross profit 4,382 3,021
Operating expenses (note 14)    
Research and development 14,377 14,690
General and administrative 9,168 9,465
Selling and distribution 9,453 8,468
Impairment of goodwill (note 7)   2,524
Total operating expenses 32,998 35,147
Operating loss 28,616 32,126
Net finance expense (income) (note 15) 81 (3,744)
Loss before income taxes 28,697 28,382
Income tax (recovery) expense (note 16) (187) 287
Deferred tax expense (note 16) 59  
Net loss attributed to shareholders for the year 28,569 28,669
Item that may be reclassified to loss    
Foreign currency translation adjustment - net of tax 4,806 (12,091)
Net loss and comprehensive loss for the year $ 33,375 $ 16,578
Loss per share (note 17)    
Basic loss per common share $ 1.35 $ 1.38
Diluted loss per common share $ 1.35 $ 1.38